| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/04/1993 | WO1993002193A1 cDNAS DERIVED FROM HEPATITIS C VIRUS |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002190A1 Production of antibodies |
| 02/04/1993 | WO1993002189A1 Transgenic animal models for alzheimer's disease |
| 02/04/1993 | WO1993002188A1 Universal donor cells |
| 02/04/1993 | WO1993002187A1 Transgenic plants producing polyhydroxyalkanoates |
| 02/04/1993 | WO1993002184A1 Papilloma virus vaccine |
| 02/04/1993 | WO1993002178A1 Apparatus and methods for electroporation and electrofusion |
| 02/04/1993 | WO1993002108A1 Recombinant antibodies for human therapy |
| 02/04/1993 | WO1993002107A1 Immunoglobulin-combining artificial protein |
| 02/04/1993 | WO1993002104A1 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1993 | WO1993002097A1 Protein v: a novel igg binding factor |
| 02/04/1993 | WO1993001833A1 Improved vaccine |
| 02/04/1993 | WO1993001830A1 Expression of enzymatically active recombinant human acetylcholinesterase and uses thereof |
| 02/04/1993 | WO1993001827A1 Osteoclast growth regulatory factor |
| 02/04/1993 | WO1992022332A3 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | DE4224050A1 Loesliche kit-liganden Soluble kit ligand |
| 02/04/1993 | DE4222416A1 Monoclonal antibody specific for prostatic acid phosphatase - shows very little cross-reactivity with phosphatase(s) from platelets, erythrocytes or leukocytes, for prostatic cancer diagnosis |
| 02/04/1993 | DE4214112A1 Neues verfahren zur sequenzierung von nukleinsaeuren New method for sequencing nucleic acids |
| 02/04/1993 | DE4122599A1 Oberflaechen-expressionsvektor zum screenen von antikoerpern A roughness expression vector for antibody screening |
| 02/04/1993 | CA2114008A1 Callase-related dnas and their use in artificial male sterility |
| 02/04/1993 | CA2113993A1 Protein v: a novel igg binding factor |
| 02/04/1993 | CA2113828A1 Osteoclast growth regulatory factor |
| 02/04/1993 | CA2113815A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | CA2113801A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | CA2113641A1 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1993 | CA2113572A1 Improved vaccine |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2111858A1 Production of antibodies |
| 02/03/1993 | EP0526009A1 Inhibitors of hiv protease useful for the treatment of aids |
| 02/03/1993 | EP0525910A1 Non-A, non-B peptide |
| 02/03/1993 | EP0525882A1 Quantification of nucleic acid |
| 02/03/1993 | EP0525828A2 Recombinant polypeptides and their uses, including assay for aids virus |
| 02/03/1993 | EP0525821A2 Methods and structures employing non-radioactive chemically-labeled polynucleotide probes |
| 02/03/1993 | EP0525610A2 Process for increasing the stability of enzymes and stabilized enzymes |
| 02/03/1993 | EP0525508A2 Anti-palnogenic protein of ustilago maydis and use thereof |
| 02/03/1993 | EP0525384A2 Imidazolinone resistant ahas mutants |
| 02/03/1993 | EP0525083A1 Erythromycin derivatives |
| 02/03/1993 | EP0525076A1 Recombinant bile salt activated lipases |
| 02/03/1993 | EP0525054A1 Modified heparin binding growth factors |
| 02/03/1993 | EP0524997A1 2'-o-alkyl nucleotides and polymers containing them. |
| 02/03/1993 | EP0233915B1 Molecular farming |
| 02/03/1993 | CN1068501A A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 02/03/1993 | CA2075165A1 Non-a, non-b peptide |
| 02/03/1993 | CA2075135A1 Particle-mediated transformation of gymnosperms |
| 02/02/1993 | WO1993003141A1 Ribozyme inhibition of bcr-abl gene expression |
| 02/02/1993 | US5183949 Rabbit model for diagnosing and testing vaccines or therapeutic agents against aids |
| 02/02/1993 | US5183885 Method for chromatographic separation of synthetic phosphorothioate oligonucleotides |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183759 Recombinant Rhizobium bacteria inoculants |
| 02/02/1993 | US5183755 Anti-human papillomavirus monoclonal antibody, hybridoma producing the same and process for preparing the same |
| 02/02/1993 | US5183748 By synthesizing the complementary strand of a single-stranded DNA piece enzymatically |
| 02/02/1993 | US5183747 Culturing from streptomyces, chromatographic isolation; nucleotides; for analyzing, cleaving DNA sequences |
| 02/02/1993 | US5183745 Adenyl cyclase derivatives and their biological uses |
| 02/02/1993 | US5183739 Hybridoma which produces antibody binds to an epitope on glycohemoglobin comprising epsilon-d-fructosyllysine is useful for diagnosis of diseases |
| 02/02/1993 | US5183734 Antibodies, diagnostic systems and methods for assaying SV40 HBxAg |
| 02/02/1993 | US5183659 Protection of equines against Streptococcus equi |
| 02/02/1993 | CA2092571A1 Ribozyme inhibition of bcr-abl gene expression |
| 02/02/1993 | CA1313359C Method of isolating and purifying nucleic acids from biological samples |
| 01/28/1993 | DE4221830A1 Escherichia coli expression vector for NADH-oxidase gene - derived from 26.8kD gene isolated from Thermus thermophilus, useful as highly stable bio-sensor |
| 01/27/1993 | EP0524910A2 Modulation of flower colour |
| 01/27/1993 | EP0524906A1 DNA coding for prolylendopeptidase |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524834A2 Immunosuppressive drugs containing a cysteine protease |
| 01/27/1993 | EP0524832A2 Activator gene for macrolide biosynthesis |
| 01/27/1993 | EP0524808A2 In situ PCR preparations, their use, and corresponding thermal cycler equipment |
| 01/27/1993 | EP0524768A2 Ribotoxins, conjugates thereof ans pharmaceutical composition |
| 01/27/1993 | EP0524681A1 Process for the purification of serum albumin |
| 01/27/1993 | EP0524672A1 CCV vaccine |
| 01/27/1993 | EP0524604A2 Process for the preparations of S-(+)-2,2-dimethyl-cyclopropane carboxamid by genetically engineered microorganismes |
| 01/27/1993 | EP0524448A1 Thermostable luciferase of a firefly, gene of a thermostable luciferase of a firefly, novel recombinant DNA, and process for the preparation of a thermostable luciferase of a firefly |
| 01/27/1993 | EP0524421A1 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/27/1993 | EP0524301A1 Ellipsometric immunoassay system and method including a thin film detection device |
| 01/27/1993 | EP0524260A1 GPIb$g(a) FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 01/27/1993 | EP0524254A1 A binary genetic system to control expression of a transgene in a transgenic animal |
| 01/27/1993 | EP0348442B1 Altered antibody |
| 01/27/1993 | CN1068335A Hepatitis c diagnostics and vaccines |
| 01/27/1993 | CN1068266A Vaccine and treatment method for human immunodeficiency virus |
| 01/27/1993 | CA2074547A1 Activator gene for macrolide biosynthesis |
| 01/27/1993 | CA2074538A1 Vectors |
| 01/26/1993 | US5182377 Probes for detection of human papillomavirus |
| 01/26/1993 | US5182376 Dna sequence for horseradish peroxidase c modified for expression in mammalian cells |
| 01/26/1993 | US5182375 DNA encoding follistatin |
| 01/26/1993 | US5182369 Method for purifying somatotropin monomers |
| 01/26/1993 | US5182260 Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them |
| 01/26/1993 | US5182211 Vaccines |
| 01/26/1993 | US5182210 Fowlpox virus promoters |
| 01/26/1993 | US5182205 Lymphocytes |
| 01/26/1993 | US5182204 Non-human carbonyl hydrolase mutants, vectors encoding same and hosts transformed with said vectors |
| 01/26/1993 | US5182200 Promotion of transcription in plants |
| 01/26/1993 | US5182196 Expression systems for overproduction of desired proteins |
| 01/26/1993 | US5182195 Method for increasing gene expression using protease deficient yeasts |
| 01/26/1993 | CA2074541A1 Organic compounds |
| 01/26/1993 | CA1313156C Aureobasidium pullulans strain, process for its preparation, and use thereof |
| 01/26/1993 | CA1313153C Hybrid seed production |
| 01/26/1993 | CA1313152C Enhancing dna sequences |
| 01/26/1993 | CA1313151C Vaccine against rinderpest virus using recombinant vaccinia virus |
| 01/26/1993 | CA1313150C Process and reagent for the specific determination of pancreas -amylase |